search
Back to results

Efficacy of Hand Exoskeleton Controlled by BCI in Post Stroke Patients (iMove)

Primary Purpose

Poststroke/CVA Paresis

Status
Completed
Phase
Not Applicable
Locations
Russian Federation
Study Type
Interventional
Intervention
hand exoskeleton, brain-computer interface (BCI),
hand exoskeleton, sham BCI
Sponsored by
Russian Academy of Medical Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Poststroke/CVA Paresis focused on measuring Post stroke hand paresis brain injury

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Signed informed consent
  • Medical history of primary acute cerebrovascular event (ischemic or hemorrhagic stroke) at least 4 weeks before screening
  • focal stroke located in a hemisphere
  • post stroke hand paresis (mild to plegia according to Medical Research Council (MRC) Scale for Muscle Strength)

Exclusion Criteria:

  • Montreal Cognitive Assessment (MoCA) scale < 22
  • Left handedness
  • Sensory aphasia
  • Severe impairment of vision
  • Modified Ashworth Scale (MAS) ≥ 4

Sites / Locations

  • Research Center of Neurology of RAMS

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Study group

Placebo group

Arm Description

Hand exoskeleton, brain-computer interface (BCI) 10 sessions of 45-minutes

Hand exoskeleton, sham BCI 10 sessions of 45-minutes (BCI imitation)

Outcomes

Primary Outcome Measures

Change from Baseline in hand paresis level and hand muscle spasticity
ARAT; Fugl-Meyer, Modified Ashworth scale

Secondary Outcome Measures

Long-term changes from Baseline in hand paresis level and hand muscle spasticity
ARAT; Fugl-Meyer, Modified Ashworth scale

Full Information

First Posted
December 8, 2014
Last Updated
September 27, 2017
Sponsor
Russian Academy of Medical Sciences
Collaborators
Pirogov Russian National Research Medical University
search

1. Study Identification

Unique Protocol Identification Number
NCT02325947
Brief Title
Efficacy of Hand Exoskeleton Controlled by BCI in Post Stroke Patients
Acronym
iMove
Official Title
A Multicentre Randomized Single Blind Placebo Controlled Study to Assess Efficacy of Hand Exoskeleton Controlled by Motor Imagery Based BCI for Post Stroke Patients Movement Rehabilitation
Study Type
Interventional

2. Study Status

Record Verification Date
September 2017
Overall Recruitment Status
Completed
Study Start Date
January 2015 (undefined)
Primary Completion Date
September 2017 (Actual)
Study Completion Date
September 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Russian Academy of Medical Sciences
Collaborators
Pirogov Russian National Research Medical University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to assess the efficacy of non-invasive BCI-exoskeleton technology based on EEG patterns recognition matching to motor imagery in post-stroke patients with hand paresis.
Detailed Description
The BCI training is based on EEG activity patterns recording during hand motor imagery. A subject sit comfortably 1m from a computer screen which presents visual instructions during the session. The robotic exoskeleton is fixed to the paretic hand. Subject visually fixate on a circle presented in the center of the screen and receive instructions from three surrounding rhomboidal arrows. Subject is given three commands instructing them to relax or imagine slow hand opening movement with the right or left hand. The "Relax" command means that the subject have to sit still and look at the center of the screen. Commands are presented randomly, each of 10 sec duration. A visual cue provides the subject with feedback regarding the mental task recognition: the central circle turned green if the classifier recognizes the task in agreement with the given command, or remains white if the signal is not recognized. In addition to visual feedback the subject is provided with kinesthetic feedback: the exoskeleton is opening the hand when the classifier recognizes the imagery of paretic hand movement. The EEG is registered with 30 electrodes distributed over the head in accordance with the standard international 10-20 system. EEG signals are filtered from 5-30Hz. A Bayesian approach for EEG pattern classifying is used in the system. The activity sources most relevant for BCI functioning will be identified using an independent component analysis (ICA). Classification accuracy will by measured with Cohen's kappa (Kohavi and Provost, 1998). The procedure may consist from up to three sessions, the duration of 1 session is 10 min, there are 5 min time brake between session and total duration of procedure is up to 45 min. The number of procedures - at least 10. The maximal interval between procedures is 3 days.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Poststroke/CVA Paresis
Keywords
Post stroke hand paresis brain injury

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
75 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Study group
Arm Type
Experimental
Arm Description
Hand exoskeleton, brain-computer interface (BCI) 10 sessions of 45-minutes
Arm Title
Placebo group
Arm Type
Sham Comparator
Arm Description
Hand exoskeleton, sham BCI 10 sessions of 45-minutes (BCI imitation)
Intervention Type
Device
Intervention Name(s)
hand exoskeleton, brain-computer interface (BCI),
Other Intervention Name(s)
mind-machine interface
Intervention Description
Hand exoskeleton, brain-computer interface (BCI) 10 sessions of 45-minutes
Intervention Type
Device
Intervention Name(s)
hand exoskeleton, sham BCI
Intervention Description
Hand exoskeleton, sham BCI 10 sessions of 45-minutes (BCI imitation)
Primary Outcome Measure Information:
Title
Change from Baseline in hand paresis level and hand muscle spasticity
Description
ARAT; Fugl-Meyer, Modified Ashworth scale
Time Frame
Week 2
Secondary Outcome Measure Information:
Title
Long-term changes from Baseline in hand paresis level and hand muscle spasticity
Description
ARAT; Fugl-Meyer, Modified Ashworth scale
Time Frame
week 4, week 12, week 24

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Signed informed consent Medical history of primary acute cerebrovascular event (ischemic or hemorrhagic stroke) at least 4 weeks before screening focal stroke located in a hemisphere post stroke hand paresis (mild to plegia according to Medical Research Council (MRC) Scale for Muscle Strength) Exclusion Criteria: Montreal Cognitive Assessment (MoCA) scale < 22 Left handedness Sensory aphasia Severe impairment of vision Modified Ashworth Scale (MAS) ≥ 4
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Roman Lyukmanov, MD
Organizational Affiliation
Russian Academy of Medical Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Research Center of Neurology of RAMS
City
Moscow
ZIP/Postal Code
125367
Country
Russian Federation

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Links:
URL
https://www.frontiersin.org/articles/10.3389/fnins.2017.00400/full
Description
Post-stroke Rehabilitation Training with a Motor-Imagery-Based Brain-Computer Interface (BCI)-Controlled Hand Exoskeleton: A Randomized Controlled Multicenter Trial

Learn more about this trial

Efficacy of Hand Exoskeleton Controlled by BCI in Post Stroke Patients

We'll reach out to this number within 24 hrs